Leptin antagonists have been proposed as potential preventative treatments for RA, offering a new avenue for personalised management of individuals at risk for developing RA, aiming to dampen the inflammatory cascade and mitigate the onset and impact of this disease [236,237]. Here, LEP is linked to rheumatoid arthritis.